DAVID C. CALVERLEY M.D.

Associate Professor of Medicine

Go To Full Curriculum Vitae

Medical School:
University of Alberta, Edmonton, Alberta, Canada
Postgraduate training:
1985-1986 Rotating Intern, University of Alberta
1986-1987 Resident, Radiation Oncology, University of British Columbia
1987-1990 Resident, Internal Medicine, University of British Columbia
1990-1992 Resident, Clinical Hematology, McMaster University
1991-1992 Chief Resident, Clinical Hematology, McMaster University
1992-1995 Senior Fellow, Division of Hematology, University of Washington
When arrived at UCD:
2001
Past and current professional positions:
1995-1997 Acting Instructor, Division of Hematology, University of Washington
1998-2000 Assistant Professor of Medicine, Division of Hematology, University of Southern California School of Medicine
1998-2000 Associate Director, USC/Norris Cancer Center Clinical Coagulation Laboratory
2001-Present Assistant Professor of Medicine, Divisions of Medical Oncology and
Hematology, University of Colorado School of Medicine
2001-Present Attending Physician, Medicine Service, Denver VAMC
Memberships and other information:
American Society of Hematology
American College of Physicians
Board Certification:
Diplomate, American Board of Internal Medicine (Internal Medicine), 1990
Diplomate, American Board of Internal Medicine (Hematology), 1992
Board Recertification, ABIM (Hematology), 2002
Awards received:
1997-2000    NIH Mentored Clinical Scientist Development (K08) Award 1998-2000    Stop Cancer Career Development Award                  1998-2000    James H. Zumberge Research Fellowship Award
1998-2000    Lymphoma Research Foundation of America Award        2000             Wright Foundation Research Grant                           2002-2004    American Diabetes Association Innovation Award
Major Scientific Interest:
The role of platelets in atherosclerosis. Our laboratory studies molecular interaction between platelets and collagen in the atherothrombotic setting.
Major Clinical Interest:
Providing consultation related to platelet disorders, bleeding disorders and hypercoagulable states that lead to premature blood clot formation.
Representative Publications:
  1. Calverley D, Haley L, Ballem P. Red blood cell alloimmunization in transfused patients on AZT. Br J Haematol 78:248-250, 1991.
  2. Calverley D, Jones G, Kelton J. Splenic radiation for corticosteroid-resistant immune thrombocytopenia. Ann Int Med 116:977-981, 1992.
  3. Calverley D, Wismer J, Rosenthal D, deSa D, Barr R. Xanthoma dissemination in an infant with skeletal and marrow involvement. Am J Pediatr Hematol Oncol 17:59-63, 1995.
  4. Calverley D, Yagi M, Stray S, Roth G. Human platelet glycoprotein V: Its role in enhancing expression of the glycoprotein Ib receptor. Blood 86:1361-1367, 1995.
  5. Calverley D, Kavanagh T, Roth G. Human Signaling Protein 14-3-3? interacts with platelet glycoprotein Ib subunits Ib? and Ib?. Blood 91:1295-1303, 1998.
  6. Pullarkat V, Pullarkat S, Calverley D, Brynes R. Systemic mastocytosis associated with acute myeloid leukemia: Report of a new c-kit mutation Asp816His. Am J Hematol 65:307-309, 2000.
  7. Calverley D, Brass E, Tsao-Wei D, Pullarkat V, Espina B, Hodis H, Groshen S. A potential role for platelet FcyRIIA in collagen-mediated platelet activation associated with atherothrombosis. Atherosclerosis 164: 261-267, 2002.
  8. Calverley D, Loda K, Brass E, Buchanan T, Tsao-Wei D, Groshen S. Increased platelet Fc receptor expression as a potential contributing cause of platelet hypersensitivity to collagen in diabetes mellitus. Br J Haematol 121: 139-142, 2003.
univeristy of colorado health sciences center department of medicine at u c h s c school of medicine at u c h s c division of infectious diseases home